The Immune Landscape in a Long-Term Survival Pancreatic Adenocarcinoma Patient Highly Responsive to a Multidisciplinary Approach With Chemo-Radio Treatments

Pancreas. 2021 Oct 1;50(9):e76-e78. doi: 10.1097/MPA.0000000000001907.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / immunology
  • Adenocarcinoma / therapy*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / blood
  • CA-19-9 Antigen / blood
  • Chemoradiotherapy / methods
  • Humans
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / diagnosis
  • Pancreatic Neoplasms / immunology
  • Pancreatic Neoplasms / therapy*
  • Radiosurgery / methods*
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • CA-19-9 Antigen